Benzerara Yahia, Gallah Salah, Hommeril Baptiste, Genel Nathalie, Decré Dominique, Rottman Martin, Arlet Guillaume
Emerg Infect Dis. 2017 Sep;23(9):1564-1567. doi: 10.3201/eid2309.170560.
FosA, a glutathione S-transferase that inactivates fosfomycin, has been reported as the cause of enzymatic resistance to fosfomycin. We show that multiple lineages of FosA-producing extended spectrum β-lactamase Escherichia coli have circulated in France since 2012, potentially reducing the efficacy of fosfomycin in treating infections with antimicrobial drug-resistant gram-negative bacilli.
FosA是一种可使磷霉素失活的谷胱甘肽S-转移酶,已被报道为磷霉素酶促耐药的原因。我们发现,自2012年以来,产生FosA的超广谱β-内酰胺酶大肠杆菌的多个谱系在法国传播,这可能会降低磷霉素治疗耐抗菌药物革兰氏阴性杆菌感染的疗效。